Jun 25, 2026 03:26AM
Jun 24, 2026 08:59PM
Apr 28, 2026 08:53PM
Apr 28, 2026 08:53PM
Apr 14, 2026 08:11PM
Apr 14, 2026 08:10PM
Apr 10, 2026 04:10PM Mesoblast receives FDA clearance for Duchenne muscular dystrophy trial
Apr 10, 2026 04:09PM
Apr 8, 2026 09:07AM
Apr 7, 2026 11:35PM
Mar 18, 2026 11:30AM
Mar 17, 2026 07:19PM
Mar 11, 2026 07:21PM
Feb 26, 2026 07:42PM Ryoncil® Profits Underpinning Substantial Growth Pipeline
Feb 11, 2026 06:27PM
Jan 28, 2026 06:54PM
Jan 26, 2026 06:45PM
Jan 18, 2026 07:01PM
Jan 8, 2026 06:46PM
Jan 1, 2026 06:02PM
Jan 1, 2026 06:02PM Mesoblast Announces Changes to Board of Directors' Leadership Roles
Dec 29, 2025 06:57PM
Dec 21, 2025 04:00AM
Dec 11, 2025 06:22PM
Dec 3, 2025 06:10PM
Nov 24, 2025 06:39PM
Nov 20, 2025 06:32PM
Nov 4, 2025 06:40PM Mesoblast to Meet With FDA Next Month to Discuss Rexlemestrocel-L and Opioid Cessation
Oct 19, 2025 07:48PM
Oct 6, 2025 07:24PM
Oct 2, 2025 09:04PM
Sep 26, 2025 01:49AM
Sep 14, 2025 09:18PM
Sep 3, 2025 09:47PM
Aug 28, 2025 08:24PM Banner Year for Mesoblast With First FDA Product Approval and Successful Commercial Launch of Ryoncil®
Jul 17, 2025 08:38PM
Jun 30, 2025 08:36PM
Jun 11, 2025 09:24PM
May 14, 2025 11:36PM
May 14, 2025 10:57PM
Apr 29, 2025 08:53PM
Apr 28, 2025 07:44PM Mesoblast Appoints Corporate Finance Leader Lyn Cobley To Board
Apr 3, 2025 06:58PM
Apr 2, 2025 07:15PM
Mar 30, 2025 07:39PM
Mar 13, 2025 07:42PM
Mar 6, 2025 06:54PM
Feb 26, 2025 05:30PM
Feb 25, 2025 06:13PM Mesoblast Financial Results and Corporate Update Webcast
Feb 23, 2025 06:33PM

324,417 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All